The Quetiapine Fumarate Tablets, cataloged under National Stock Number 6505-01-693-4566, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Astrazeneca Pharmaceuticals Lp. The record lists 2 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 4 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-693-4566 |
| Primary Part Number | NDC00310-0281-60 |
| Item Name | Quetiapine Fumarate Tablets |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Astrazeneca Pharmaceuticals Lp |
| Status | ACTIVE |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC00310-0281-60 | Astrazeneca Pharmaceuticals Lp (USA) |
| NDC52818-0161-60 | Trupharma Llc (USA) |
| Reference | Meaning |
|---|---|
| 1589159 | 5/1 Secondary reference U.S. Government activity |
| 6505NCM216859 | 5/1 Secondary reference Defense Medical Standardization Board |
| SEROGUEL XR | 5/1 Secondary reference Astrazeneca Pharmaceuticals Lp |
| NDC51407-0074-60 | 3/9 Design control — primary reference Golden State Medical Supply, Inc. Dba Golden State Medical Supply Inc |
NSN 6505-01-693-4566 is a Quetiapine Fumarate Tablets, manufactured by Astrazeneca Pharmaceuticals Lp, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-693-4566 has 2 manufacturer part numbers on file: NDC00310-0281-60 (Astrazeneca Pharmaceuticals Lp), NDC52818-0161-60 (Trupharma Llc).
Key specifications for NDC00310-0281-60: Special Features: QUETIAPINE FUMARATE EXTENDED-RELEASE TABLETS ARE INDICATED FOR THE TREATMENT OF SCHIZOPHRENIA; INDICATED FOR THE ACUTE TREATMENT OF MANIC OR MIXED EPISODES ASSOCIATED WITH BIPOLAR I DISORDER, BOTH AS MONOTHERAPY AND AS AN ADJUNCT TO LITHIUM OR DIVALPROEX; 150 MG QUETIAPINE FUMARATE EXTENDED-RELEASE TABLETS ARE WHITE, FILM-COATED, CAPSULE-SHAPED, BICONVEX, DEBOSSED TABLET WITH "NT 150" ON ONE SIDE AND PLAIN ON THE OTHER SIDE; STORE QUETIAPINE FUMARATE EXTENDED-RELEASE TABLETS AT 25 C (77 F); EXCURSIONS PERMITTED TO 15-30 C (59-86 F) (SEE USP CONTROLLED ROOM TEMPERATURE); SWALLOW WHOLE - DO NOT SPLIT, CRUSH OR CHEW; BOTTLE OF 60 TABLETS.; Part Name Assigned by Controlling Agency: QUETIAPINE FUMARATE TABLETS, 150MG, 60S. 0 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.